Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating income | -$19.5M | -$37.5M | -$50.2M | -$37.1M | -$32.6M | -$22.3M |
| Net income | -$20.1M | -$36.8M | -$48.6M | -$34.1M | -$30.2M | -$21.1M |
| EPS (diluted) | -$12.53 | -$1.33 | -$1.58 | -$1.22 | -$24.01 | -$16.72 |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$17.7M | -$30.3M | -$39.0M | -$32.0M | -$24.7M | -$20.5M |
| Capital expenditures | $1.21M | $2.03M | $321K | $180K | $146K | $16.0K |
| Free cash flow | -$18.9M | -$32.3M | -$39.3M | -$32.2M | -$24.8M | -$20.5M |
| Share buybacks | — | — | — | $10.4M | — | — |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $16.6M | $7.16M | $17.8M | $13.0M | $9.99M | $8.67M |
| Total assets | $21.4M | $153M | $118M | $74.4M | $45.4M | $22.9M |
| Total liabilities | $5.54M | $6.71M | $15.0M | $9.48M | $6.97M | $4.31M |
| Long-term debt | $567K | — | — | — | — | — |
| Shareholders' equity | -$56.4M | $147M | $103M | $64.9M | $38.4M | $18.6M |
| Retained earnings | -$112M | -$149M | -$198M | -$232M | -$262M | -$283M |
| Shares (wtd avg diluted) | 1.88M | 27.7M | 30.7M | 28.0M | 1.26M | 1.26M |
Every figure is extracted from Sensei Biotherapeutics, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.